Visningssätt för begreppens/termernas förhållanden:
Det sätt begreppsrelationer visas:
Det sätt begreppsrelationer visas:
Daktinomycin
Hierarki: | ∟ ∟ ∟ ∟ Daktinomycin 40 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Faloidin | ∟ ∟ ∟ ∟ ∟ ∟ Nisin | ∟ ∟ ∟ ∟ ∟ ∟ Viomycin | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Flaviner | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Daktinomycin 40 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Faloidin | ∟ ∟ ∟ ∟ ∟ ∟ Nisin | ∟ ∟ ∟ ∟ ∟ ∟ Viomycin | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Flaviner | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Daktinomycin 40 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Faloidin | ∟ ∟ ∟ ∟ ∟ ∟ Nisin | ∟ ∟ ∟ ∟ ∟ ∟ Viomycin | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Flaviner | ∟ ∟ ∟ ∟ ∟ ∟ |
Bredare villkor: | |
Anmärkning: | A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015)
X |
historyNote*: | 66; ACTINOMYCIN was heading 1963-95
X |
publicMeSHNote*: | 66; ACTINOMYCIN was heading 1963-95
X |
activeMeSHYear*: | |
dateCreated*: | 1999-01-01X |
dateEstablished*: | 1966-01-01X |
dateRevised*: | 2005-06-30X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | exlX |
recordOriginator*: | NLMX |
Typ: | |
Samordna villkor: | |
URI: | |
Termer och motsvarande begrepp: | Daktinomysiini (fi) XAktinomysiini D (fi, ersatt) Actinomycin (sv, ersatt) Cosmegen (sv, ersatt) Dactinomycin (en) MSD Brand of Dactinomycin (en, ersatt) Merck Sharp & Dohme Brand of Dactinomycin (en, ersatt) Merck Frosst Brand of Dactinomycin (en, ersatt) Merck Brand of Dactinomycin (en, ersatt) Cosmegen Lyovac (en, ersatt) Lemery Brand of Dactinomycin (en, ersatt) Lyovac-Cosmegen (en, ersatt) Meractinomycin (en, ersatt) Actinomycin D (en, ersatt) |
Dela: |
Laddar resultat...